We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Nestor Health. | LSE:NSR | London | Ordinary Share | GB0006313034 | ORD 10P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 109.50 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 109.50 | GBX |
Nestor Healthcare (NSR) Share Charts1 Year Nestor Healthcare Chart |
|
1 Month Nestor Healthcare Chart |
Intraday Nestor Healthcare Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 22/12/2010 | 11:09 | Nestor Healthcare | 537 |
| 08/6/2009 | 16:22 | Directors Buying at Nestor | 492 |
| 10/11/2003 | 14:17 | very good news shortly | 61 |
| 11/4/2001 | 11:34 | Nestor Health - why the rise? | - |
| 24/1/2001 | 22:37 | nestor - price rise? | 1 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 06/12/2010 08:16 by kimball808 don't forget the juicy dividend on Christmas eve...Sorry wrong thread...NSR...what am i doing this am...Think I'll just go back to bed |
Posted at 06/12/2010 07:12 by kimball808 tis a merry Xmas for NSR holders..well done all |
Posted at 22/11/2010 12:37 by pstubbs50 The price has stayed static for ages - common sense says that something is around the corner now..imho of course! |
Posted at 22/11/2010 09:00 by nellie1973 News soon, price is moving! |
Posted at 01/11/2010 18:15 by miikke Has a date been set for the Interim management statement?Crossed my mind that if the deal doesn't materialise and the share price falls a lot it could then recover if the IMS was positive...but fall further if the IMS is less rosy. Any thoughts? |
Posted at 07/10/2010 11:46 by cockneyrebel Yep, I'd say todays statement is a last call to other bidders imo.I'd say Acromas get the co for 105-110p if there's no other bidder. Looking at the trades this am I'd say Acromas are taking what they can get at this level and know it's a win win for them - they either pick up shares below the current £1 negotiation price or they sell on to another bidder at a higher price. It's job done now tho imo - just how much over the 100p level gets paid. T/S from NSR due at the end of the month - reckon we'll only need to wait till then for Acromas final price or news of another bidder imo. CR |
Posted at 07/10/2010 08:51 by mg1982 Ratel, Blackstone are aware that NSR are in talks with Acromas, how can they not be, when they are just as keen as Acromas to acquire the same businesses? They a) are either waiting for those talks to advance so that they can then assess if it is worth paying more, b) they are not interested as they do not think NSR would fit into their strategy (for whatever reason) or c) they are well aware how much schroders and gartmore each hold and may even approach one or maybe even both for 'advice'waiting game but it will be worth it. |
Posted at 07/10/2010 08:36 by fishbournetrader With every other company that I have been involved in which has had a bid the share price has risen to the bid price or higher. Whilst the 100p may not be a formal offer I am surprised the offer price has not risen higher then the current 95p. Any ideas why? |
Posted at 05/10/2010 20:35 by trendfloor Just off the press floor........Nestor Healthcare jumps on talk of raise offer Nestor Healthcare was back in the spotlight amid talk that its suitor has significantly raised its takeover offer for the business. Published: 8:05PM BST 05 Oct 2010 The chatter is that Acromas, the company behind AA and Saga, has increased its bid for Nestor, down 3¼ to 86½p, from 90p a share to 100p. The move comes after Nestor rejected Acromas's offer of 90p a share in August. Sources said that although Nestor's board is now minded to recommend Acromas's offer, some shareholders are keen for the business to hold out for a price of between 105p and 110p a share. Indeed, The Sunday Telegraph revealed that Acromas has been holding tentative negotiations with Allied Healthcare after it appointed advisers from US investment bank Oppenheimer to look at "strategic options" for the group. Sources, though, cautioned that Acromas has yet to make a formal offer for Allied Healthcare. Overall, the FTSE 100 jumped by 79.79 points to 5635.76 and the FTSE 250 surged by 118.15 points to 10681.96. Joshua Raymond, market strategist at City Index, said: "Better-than-expecte British Airways climbed to the top of the blue-chip leaderboard after better-than-expected traffic figures. The airline's shares surged 15½ to 254.6p after it revealed a 1.3pc increase in revenue passenger kilometres for September, helped by an increase in first and business-class travel. The rise is the biggest gain since August 2008, the month before the collapse of Lehman Brothers. Citigroup upgraded technology group Invensys to "buy", which helped the shares gain 9.2 to 307.2p. Mark Fielding, an analyst at Citigroup, said: "Concerns over its late cycle nature and the risks to growth in rail have weighed on the shares over the last year. However, our analysis suggests continued growth... at rail. When this is combined with recovery continuing across the rest of the portfolio we see renewed attractions in the share." InterContinental Hotels Group advanced 19p to £11.46 as JP Morgan Cazenove gave the stock a push on valuation grounds. Tim Barrett, an analyst at JP Morgan Cazenove, said: "The outlook for 2011 is favourable and likely to be an increasing focus for investors after Marriott and Starwood publish 2011 guidance with their third-quarter results. We believe low supply growth in 2011 is likely to support [revenue per available room] growth of between 5pc and 8pc in 2011." BT Group put on 2.7 to 148½p amid talk Ofcom will this week announce a decision on superfast broadband that is likely to be favourable to the telecoms company. Tui Travel rallied 9.1 to 225.9p after it said in a trading update that it had a good summer and bookings were picking up. Elsewhere in the sector, rival Thomas Cook increased 6.7 to 179¾p. Hedge fund group Man Group perked up 9½ to 227.1p after it said its Athena Guaranteed Futures rose 0.55pc last month and had risen 10.5pc over the past 12 months. Gold mining stocks were in vogue as the price of the precious metal flirted with a fresh high. Randgold Resources climbed 195p to £66.55. Rising risk appetite gave base metal mining companies and banking stocks a lift. Anglo American put on 103½p to £26.41 and Barclays edged up 9 to 308.8p. Aviva advanced 3.4 to 396.2p despite the fact that Bank of America Merrill Lynch argued that the latest "bid" related spike in the transport group's shares will unwind as the likelihood of any corporate activity lessens. On a less positive tack, Inmarsat fell 26 to 629p. After the market closed yesterday, Harbinger Capital confirmed it had sold 65m shares - about 14pc of the company at 630p a share in a move that raised £410m. The share sale was larger than expected and triggered speculation Harbinger could sell the rest of the its holding once the 180-day lock-up expires. Among the smaller companies, Computacentre jumped 22.9 to 322.9p as Investec upgraded the stock to "buy" from "hold". "We believe earnings quality has improved through operational efficiencies, managed services traction and cost savings. The outlook suggests a continuation of these trends, reasonable revenue progress and modest forecast momentum," said Julian Yates, an analyst at Investec. "Buy" advice from Barclays Capital lifted Carphone Warehouse 3¼ to 266p. Karen Howland, an analyst at Barclays Capital, said: "We expect Carphone Warehouse to report another set of strong figures during its second-quarter results on November." Homeserve also rallied 17.1 to 459.1p after Credit Suisse took up coverage with an "outperform" rating and a 720p price target. Analysts at Credit Suisse said: "HomeServe offers one of the most compelling combinations of growth, profitability and value in Europe." Weir Group put on 33p to £14.86 as Bank of America Merrill Lynch argued it is likely to offer "superior growth" in an economic cycle that is "settling down". However, oil services company Wood Group slipped 3.3 to 424.6p as Morgan Stanley downgraded it to "equalweight". "The recovery we identified in engineering as the key 'swing factor' for its earnings recovery in 2011 is being priced in," said Martjin Rats, an analyst at Morgan Stanley. Vallar, Nat Rothchild's investment vehicle, is still trading below its issue price of £10.00 a share. When Vallar floated in July, investors had high hopes for the financier's plans to consolidate some of the mining sector. However, Vallar, up 15 to 920p, has failed to carry out a transaction since its float and some investors are preparing to kick up a fuss if the shares fail to move higher. |
Posted at 03/10/2010 14:02 by mg1982 excellent news for us, an indirect news update for NSR. we now know that there is a possibility of 2 bids - Acromas and Blackstone, this would explain the current price being more than 90p. Add to this that both Schroders and Gartmore have more than 29% each. I wouldnt be surprised if they approached other potential suiters to boost the price even further. I have been holding these when they were 30p and have no intention of selling until they have a bid which will happen, even if not now, in the near future. We should expect an update from NSR wc 11th oct.taken from: "...Acromas's interest in Allied Healthcare comes as it also holds talks to buy Nestor Healthcare, a UK-listed provider of social and primary care services. In August, Acromas, which is owned by buy-out firms CVC Capital Partners, Charterhouse and Permira, said that it had written to the board of Nestor outlining plans to make a 90p a share bid. However, Nestor said that the unsolicited approach by Acromas "materially undervalued the company and was therefore rejected". Industry sources, though, reckon Acromas is now carrying out due diligence on Nestor, which generates two-thirds of its revenue from social care for patients in their home and about a third from primary care of patients. Acromas is not the only company looking to consolidate part of Britain's fragmented healthcare sector. Earlier this year, US private equity giant Blackstone snapped up Independent Clinical Services (ICS) for £130m. Blackstone is now in negotiations to buy Pulse, the staffing agency for doctors, nurses and social workers. The buy-out giant is then likely to merge Pulse with ICS. Meanwhile it was reported last nightthat Hugh Osmond is eyeing Blackstone's Alliance Medical through Horizon, his quoted bid vehicle. Allied Healthcare and Acromas both declined to comment." |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
